"This study gives us the clearest picture to date of two different pathways that might be going wrong in people with schizophrenia," said study lead author Patrick F Sullivan from the University of North Carolina School of Medicine. (Agencies)
"Now we need to concentrate our research very urgently on these two pathways in our quest to understand what causes this disabling mental illness," he said.
The results are based on a multi-stage analysis that began with a Swedish national sample of 5,001 schizophrenia cases and 6,243 controls, followed by a meta analysis of previous genome-wide association studies, and finally by replication of single nucleotide polymorphisms (SNPs) in 168 genomic regions in independent samples.
The total number of people in the study was more than 59,000. One of the two pathways identified by the study, Sullivan said, is a calcium channel pathway. This pathway includes the genes CACNA1C and CACNB2, whose proteins touch each other as part of an important process in nerve cells.
The other is the "micro-RNA 137" pathway. This pathway includes its namesake gene, MIR137 - which is a known regulator of neuronal development - and at least a dozen other genes regulated by MIR137.
"What's really exciting about this is that now we can use standard, off-the-shelf genomic technologies to help us fill in the missing pieces," Sullivan said.
"We now have a clear and obvious path to getting a fairly complete understanding of the genetic part of schizophrenia. That wouldn't have been possible five years ago," he said.
Collaborators in the study include co-authors from the Karolinska Institutet in Stockholm, Sweden, the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard, and the Mt Sinai School of Medicine in New York.
"This study gives us the clearest picture to date of two different pathways that might be going wrong in people with schizophrenia," said study lead author Patrick F Sullivan from the University of North Carolina School of Medicine.